Disposable Syringes Market To Reach USD 11.00 Billion By 2026 | Reports And Data Print E-mail
Thursday, 10 October 2019 07:51

New York, Oct. 10, 2019 (GLOBE NEWSWIRE)

New York, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Product launches, company expansions and partnerships, the rising cases of chronic illnesses, rise in awareness about health, and technological advancements are key factors contributing to high CAGR of the disposable syringes market during forecast period.

According to the current analysis of Reports and Data, the Disposable Syringes Market has an estimated value of USD 7.10 billion in 2018 and with a CAGR of 5.6% is projected to reach USD 11.00 billion by 2026 .The market is mainly driven by the rising incidence of chronic illnesses requiring injections, advancement of technology, incorporation of IT within the healthcare industry, high amounts of investment, and improved R&D efforts. A disposable syringe is a small, simple piston pump based medical tool used to administer injections of intravenous drugs into the bloodstream, or to draw a blood sample from a patient’s body.

Disposable syringes are used for various applications, most popular being, blood recovery, insulin injections, vaccinations, and anesthesia applications. There are various types of syringes that can be used by the medical profession as per the demand of the situation. Medication through disposable syringes is the best way to avoid infection. Unsafe safety practices such as reuse of syringes account for most of the infections, especially if not properly sanitized. Unsterilized needles are particularly a safety concern in poor or undeveloped areas where injections aren’t usually given the guidance of a medical professional. Therefore, disposable syringes are advised over reusable needles for any injection to prevent the risk of blood-borne diseases as it has been contaminated with infected blood.

Earlier, the medication system was not that developed, but in the modern and advanced time, better medication through disposable syringes is possible. It is highly appropriate for the use in immunization by improving the injection safety. The increasing prevalence of chronic ailments requiring subcutaneous administration, convenient and practical approach of equipment handling, predictable amount of drug to be delivered parentally, improved medical diagnosis, technical advancements in medical tools and equipment, increasing awareness among people, increase in diabetic population are anticipated to boost the market growth. However, the rise in environmental concern has led to the formation of strict regulations and norms. Disposable syringes can cause serious health hazards if not discarded properly. These are the major restraining factors that may hamper the market.

The report provides a basic overview of the market, including definitions, segmentation, drivers, constraints, opportunities, threats, challenges, investment opportunities, and industry chain structure. This market analysis also considers development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed, as well as cost structures are also analyzed. This report also shows supply and demand Figures, cost, price, revenue, and gross margins.    

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/2031

Further key findings from the report suggest

  • Disposable Syringes market is growing at a CAGR of 6.6% in Asia Pacific followed by North America and Europe, with 5.5% and 5.3% CAGR, respectively. The growing incidences of chronic illness that require injections is the key factor that accelerates the market growth during forecast period across all regions
  • As of 2018, the safety syringe segment dominates the market holding a whopping 3% market share because safety measures associated with disposable syringes are high so as to the prevent the contact of contaminants and the skin.
  • The specialized syringe segment is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 7.8%.
  • Based on end use, hospitals held the largest market share holding over 66.5% of the market in 2016 because of the frequent usage of needle and syringes by medical practitioner for drug administration and significant increase in the diseases.
  • The diabetic care center segment is expected to be the fastest growing market segment based on end use during forecast period 2019-2026 with a CAGR of 7.9% because of the increasing prevalence of diabetes globally and development of self-injectable and injection pens.
  • North America is the highest revenue generator holding a market revenue share of 47.1% in 2018 due to the presence target diseases, rising self-management awareness, and extensive research and development activities conducted within the region
  • Europe held a 25.6% share of the global Disposable Syringes market in 2018, due to increased focus on health and increased demand for Botox in cosmetic surgery in the region.
  • Various limitations like strict regulation on the disposal of plastic and bio hazardous waste is likely to hinder the market growth during the forecast period.
  • Key participants Braun Medical, Inc.; Fresenius Kabi AG;Baxter International, Inc.; Flextronics International Vita Needle Company; Terumo Corporation; Novo Nordisk; UltiMed, Inc. ;Henke-Sass, Wolf; Covidien; Retractable Technologies, Inc.; and Becton, Dickinson and Company

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/disposable-syringe-market

Segments covered in the report:

This report predicts revenue growth and CAGR at a global, regional & country level, and analyzes the markets by studying the drivers, constraints, opportunities, threats, challenges, Investment opportunities, products, uses, trends, market shares in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the global Disposable Syringes market report based on product type, application, end use and region:                          

Product type Outlook (Revenue, USD Million; 2016-2026)

  • General Syringes
  • Specialized Syringes
  • Safety Syringes
  • Pre-filled Syringes
  • Others

Application Outlook (Revenue, USD Million; 2016-2026)

  • Immunization Injections
  • Therapeutic Injections

End Use Outlook (Revenue, USD Million; 2016-2026)

  • Hospitals
  • Blood collection centers
  • Diabetic centers
  • Veterinary Clinics
  • Others

Order Now: https://www.reportsanddata.com/checkout-form/2031

Regional Outlook (Revenue, USD Million; 2016-2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Latin America
  • Brazil

Browse more similar reports on Medical Devices category by Reports And Data

Dental X-Ray Market - https://www.reportsanddata.com/report-detail/dental-x-ray-market

Artificial Ventilators and Anesthesia Masks Market - https://www.reportsanddata.com/report-detail/artificial-ventilators-and-anesthesia-masks-market

Apheresis Equipment Market - https://www.reportsanddata.com/report-detail/apheresis-equipment-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:  John Watson  Head of Business Development  Reports And Data | Web: www.reportsanddata.com  Direct Line: +1-800-819-3052  E-mail: [email protected]  

Primary Logo

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!